Marie-annick A. Buendia
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 29, 2020
Hepatitis B virus replicating in hepatocellular carcinoma encodes HBx variants with preserved ability to antagonize restriction by Smc5/6.
Journal: Antiviral research
Published: April 08, 2019
New insights into diagnosis and therapeutic options for proliferative hepatoblastoma.
Journal: Hepatology (Baltimore, Md.)
Published: July 25, 2017
Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant.
Journal: Hepatology (Baltimore, Md.)
Published: May 04, 2017
Molecular classification of hepatoblastoma and prognostic value of the HB 16-gene signature.
Journal: Hepatology (Baltimore, Md.)
Published: March 30, 2017
MicroRNA therapy inhibits hepatoblastoma growth in vivo by targeting β-catenin and Wnt signaling.
Journal: Hepatology communications
Published: December 22, 2016
LIM-Only Protein FHL2 Is a Negative Regulator of Transforming Growth Factor β1 Expression.
Journal: Molecular and cellular biology
Published: November 29, 2016
HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase.
Journal: Journal of hepatology
Published: March 04, 2015
Hepatocellular carcinoma.
Journal: Cold Spring Harbor perspectives in medicine
Published: February 04, 2015
Unravelling the genetics of hepatoblastoma: few mutations, what else?
Journal: Journal of hepatology
Published: September 09, 2014
Last Updated: 09/26/2026